PD-1 levels were significantly higher on PD-1+CD39+CD8+ TILs relative to PD-1+CD39–CD8+ TILs (Figure 2A and Supplemental Figure 3A), identifying them as PD-1 “high” CD8+ T cells described in other tumor types (15). This evidence concerns the gene ENTPD1 and neoplasm.